Swiftwater, Pa – June 3, 2011 - Sanofi-aventis U.S. kicked off National Employee Wellness Month (NEWM) by promoting a variety of programs to encourage healthy habits with its employees. NEWM is an annual initiative that helps business leaders learn how companies have developed successful strategies around prevention and good health.
“As part of a leading global diversified healthcare company, we understand the impact that a balanced body and mind can have in overall well-being not just for our employees, but for people everywhere,” said Judy O’Hagan, Vice President of Human Resources for sanofi-aventis U.S. “To help people achieve better health, as a society we’re going to have to do a better job of preventing and treating chronic diseases. One place this can start is in the workplace by promoting good health with employees, their families and the communities in which they work.”
Kicking-off on June 1 and continuing through the month of June, sanofi-aventis U.S. is launching a “Walking Club” across all U.S. facilities in partnership with the American Heart Association’s 'Start! Walking at Work' Program.
The company offers a variety of health and wellness programs at sites across the United States, including the sanofi-aventis U.S. Headquarters and R&D sites in Bridgewater, NJ; Sanofi Pasteur’s U.S. facility in Swiftwater, Pa.; Chattem, the company's consumer health business, in Chattanooga, Tenn., and an R&D site in Tucson, Ariz.
Sites have the flexibility to implement programs that most suit their on-site teams and facilities. In addition to the walking clubs, some of the on-site available programs include: biking clubs, Weight Watchers at Work, blood pressure screenings, diabetes screenings, mammogram program, Mind & Body programs, fitness centers, and participation in recreation leagues.
In Swiftwater, Pa, examples of wellness initiatives and benefits include a walking trail, wellness screenings, health focused “Lunch & Learn” programs, health laboratory services, and immunization programs. Weight Watchers at Work and an on-site fitness center are also available to Sanofi Pasteur employees at this location.
About National Employee Wellness Month
Forward-thinking organizations across the U.S. are taking action to control rising healthcare costs and are focusing on prevention as one of the best strategies to counter the trend. National Employee Wellness Month showcases how supportive social communities, such as the workplace, can help to improve employee health and productivity and lower healthcare costs, and how leveraging an individual’s social connections helps create and sustain a workplace culture of health. Together, the supporting National Employee Wellness Month organizations and their employees understand that intelligent health decisions and supportive social communities can create a healthy, more productive workforce. Information and resources about workplace wellness, along with suggested ideas for celebrating National Employee Wellness Month, can be found at www.nationalemployeewellnessmonth.com
About sanofi-aventis U.S.
Sanofi-aventis U.S. is an affiliate of Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, please visit www.sanofi-aventis.us or www.sanofi.com
About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit: www.sanofipasteur.com or www.sanofipasteur.us
Forward Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group’s ability to benefit from external growth opportunities as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2010. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.
Media Contact:
Ellyn Schindler
Sanofi Pasteur US
Media Line: (570) 957-0717
ellyn.schindler@sanofipasteur.com
www.sanofipasteur.us
